Delhi High Court Restores Ban on Two Diabetes Fixed-Dose Combination Drugs

The Delhi High Court has reinstated the ban on two fixed-dose combination (FDC) drugs used for treating Type II diabetes, originally prohibited by the government in 2018. The court ruled that under Section 26A of the Drugs and Cosmetics Act, the government need not prove actual harm but can act on reasonable risk to public health. This decision overturned a 2019 single-judge ruling that had quashed the ban, emphasizing the court's limited role in scientific evaluations and supporting precautionary regulatory measures.